SELLAS Life Sciences Group

SLS

NASDAQHealth Care

Income Statement

Total Revenue$0

Gross Profit$0

Operating Income$-31.51M

EBITDA$-30.32M

EBIT$-30.88M

Pre-tax Income$-26.86M

Net Income$-30.88M

Cash Equivalent$15.72M

Total Debt$767.5K

Book Value$9.49M

Book Value Per Share0.15

Return on Equity (ROE)-327.52%

Return on Assets (ROA)-159.53%

Return on Invested Capital (ROI)-327.52%

Net Profit Margin-4130.00%

Current Ratio1.72

Quick Ratio1.47

Long-Term Debt / Equity0.00